Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer

This is a nationwide cohort study on integrated traditional Chinese and Western medicine for colorectal cancer. The aim is to elucidate the distribution patterns of TCM syndromes in colorectal cancer and colorectal adenoma, reveal the relationship between TCM syndromes and diagnosis, prognosis, and prognosis. Based on biological samples, a phenotypic omics study of TCM syndromes in colorectal cancer and colorectal adenoma is conducted.

NCT Number	NCT06136026
Lead Sponsor	Jiangsu Famous Medical Technology Co., Ltd. Collaborators: Jiangsu Province Hospital of Traditional Chinese Medicine, Peking University Cancer Hospital & Institute, Fujian Cancer Hospital, Hubei Cancer Hospital, Shandong Cancer Hospital and Institute, Shanxi Province Cancer Hospital, Sichuan Cancer Hospital and Research Institute, Yunnan Cancer Hospital, Zhejiang Cancer Hospital, Xiangya Hospital of Central South University, Chongqing University Cancer Hospital, The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital of Guangxi Medical University, First Affiliated Hospital of Harbin Medical University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Gansu Cancer Hospital
Conditions	Colorectal Cancer, Colorectal Adenoma
Enrollment	50,000 participants
Start Date	2023-12-01
Primary Completion	2028-12-31 (estimated)
Study Completion	2033-12-31 (estimated)
Updated on ClinicalTrials.gov	2023-11-18